Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 460

1.

Deleterious mtDNA Mutations are Common in Mature Oocytes.

Ma H, Hayama T, Van Dyken C, Darby H, Koski A, Lee Y, Gutierrez NM, Yamada S, Li Y, Andrews M, Ahmed R, Liang D, Gonmanee T, Kang E, Nasser M, Kempton B, Brigande J, McGill TJ, Terzic A, Amato P, Mitalipov S.

Biol Reprod. 2019 Oct 17. pii: ioz202. doi: 10.1093/biolre/ioz202. [Epub ahead of print]

PMID:
31621839
2.

The Regenerative Horizon: Opportunities for Nursing Research and Practice.

Chlan LL, Tofthagen C, Terzic A.

J Nurs Scholarsh. 2019 Nov;51(6):651-660. doi: 10.1111/jnu.12520. Epub 2019 Sep 30.

PMID:
31566894
3.

Path Toward Proactive Therapy for Patent Ductus Arteriosus.

Yamada S, Terzic A.

Clin Pharmacol Ther. 2019 Aug 21. doi: 10.1002/cpt.1583. [Epub ahead of print] No abstract available.

PMID:
31433488
4.

Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients.

Zhu Y, Tonne JM, Liu Q, Schreiber CA, Zhou Z, Rakshit K, Matveyenko AV, Terzic A, Wigle D, Kudva YC, Ikeda Y.

Stem Cell Reports. 2019 Aug 13;13(2):307-321. doi: 10.1016/j.stemcr.2019.07.006. Epub 2019 Aug 1.

5.

Brief Report: Ventricular Remodeling in Ischemic Heart Failure Stratifies Responders to Stem Cell Therapy.

Yamada S, Arrell DK, Rosenow CS, Bartunek J, Behfar A, Terzic A.

Stem Cells Transl Med. 2019 Aug 2. doi: 10.1002/sctm.19-0149. [Epub ahead of print]

6.

Building the regenerative medicine workforce of the future: an educational imperative.

Wyles SP, Terzic A.

Regen Med. 2019 Jul;14(7):613-615. doi: 10.2217/rme-2019-0072. Epub 2019 Jul 25. No abstract available.

7.

Two-Dimensional Black Phosphorus and Graphene Oxide Nanosheets Synergistically Enhance Cell Proliferation and Osteogenesis on 3D Printed Scaffolds.

Liu X, Miller AL 2nd, Park S, George MN, Waletzki BE, Xu H, Terzic A, Lu L.

ACS Appl Mater Interfaces. 2019 Jul 3;11(26):23558-23572. doi: 10.1021/acsami.9b04121. Epub 2019 Jun 14.

PMID:
31199116
8.

CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.

Wyles CC, Paradise CR, Houdek MT, Slager SL, Terzic A, Behfar A, van Wijnen AJ, Sierra RJ.

Clin Orthop Relat Res. 2019 Aug;477(8):1800-1812. doi: 10.1097/CORR.0000000000000713.

PMID:
31135556
9.

Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial Revascularization.

Osmanovic E, Ostojic M, Avdic S, Djedovic S, Delic A, Kadric N, Terzic A, Avdic-Salihovic A.

Med Arch. 2019 Feb;73(1):19-22. doi: 10.5455/medarh.2019.73.19-22.

10.

Human pre-valvular endocardial cells derived from pluripotent stem cells recapitulate cardiac pathophysiological valvulogenesis.

Neri T, Hiriart E, van Vliet PP, Faure E, Norris RA, Farhat B, Jagla B, Lefrancois J, Sugi Y, Moore-Morris T, Zaffran S, Faustino RS, Zambon AC, Desvignes JP, Salgado D, Levine RA, de la Pompa JL, Terzic A, Evans SM, Markwald R, Pucéat M.

Nat Commun. 2019 Apr 26;10(1):1929. doi: 10.1038/s41467-019-09459-5.

11.

Regeneration for All: An Odyssey in Biotherapy.

Behfar A, Terzic A.

Eur Heart J. 2019 Apr 1;40(13):1033-1035. doi: 10.1093/eurheartj/ehz095. No abstract available.

PMID:
30933287
12.

Regenerative medicine curriculum for next-generation physicians.

Wyles SP, Hayden RE, Meyer FB, Terzic A.

NPJ Regen Med. 2019 Feb 7;4:3. doi: 10.1038/s41536-019-0065-8. eCollection 2019. Review.

13.

Sarcolemmal α2-adrenoceptors in feedback control of myocardial response to sympathetic challenge.

Alekseev AE, Park S, Pimenov OY, Reyes S, Terzic A.

Pharmacol Ther. 2019 May;197:179-190. doi: 10.1016/j.pharmthera.2019.01.007. Epub 2019 Jan 28. Review.

14.

Are Sports-Related Factors Correlated to the Prevalence and Initiation of Illicit Drug Misuse in Adolescence? Prospective Study in Older Adolescents.

Zubak Z, Terzic A, Zenic N, Ostojic L, Zubak I, Jelicic M, Pojskic H.

Biomed Res Int. 2018 Nov 28;2018:1236284. doi: 10.1155/2018/1236284. eCollection 2018.

15.

Health Care Evolves From Reactive to Proactive.

Waldman SA, Terzic A.

Clin Pharmacol Ther. 2019 Jan;105(1):10-13. doi: 10.1002/cpt.1295. No abstract available.

PMID:
30597564
16.

Strontium-substituted hydroxyapatite stimulates osteogenesis on poly(propylene fumarate) nanocomposite scaffolds.

Li J, Liu X, Park S, Miller AL 2nd, Terzic A, Lu L.

J Biomed Mater Res A. 2019 Mar;107(3):631-642. doi: 10.1002/jbm.a.36579. Epub 2018 Nov 25.

PMID:
30422387
17.

Regenerative Prophylaxis In Utero.

Ruano R, Enninga EAL, Brana Rivera PE, Terzic A.

Clin Pharmacol Ther. 2019 Jan;105(1):39-41. doi: 10.1002/cpt.1262. Epub 2018 Nov 11. Review.

PMID:
30417507
18.

Educational and sport factors as predictors of harmful alcohol drinking in adolescence: a prospective study in Bosnia and Herzegovina.

Zenic N, Terzic A, Ostojic L, Sisic N, Saavedra JM, Kristjánsdóttir H, Guðmundsdóttir ML, Sekulic D.

Int J Public Health. 2019 Mar;64(2):185-194. doi: 10.1007/s00038-018-1168-5. Epub 2018 Oct 31.

PMID:
30382286
19.

M3RNA Drives Targeted Gene Delivery in Acute Myocardial Infarction.

Singh RD, Hillestad ML, Livia C, Li M, Alekseev AE, Witt TA, Stalboerger PG, Yamada S, Terzic A, Behfar A.

Tissue Eng Part A. 2019 Jan;25(1-2):145-158. doi: 10.1089/ten.TEA.2017.0445. Epub 2018 Sep 21.

PMID:
30047313
20.

The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential.

Nath KA, O'Brien DR, Croatt AJ, Grande JP, Ackerman AW, Nath MC, Yamada S, Terzic A, Tchkonia T, Kirkland JL, Katusic ZS.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1493-F1499. doi: 10.1152/ajprenal.00308.2018. Epub 2018 Jul 18.

21.

Effective nerve cell modulation by electrical stimulation of carbon nanotube embedded conductive polymeric scaffolds.

Zhou Z, Liu X, Wu W, Park S, Miller Ii AL, Terzic A, Lu L.

Biomater Sci. 2018 Aug 21;6(9):2375-2385. doi: 10.1039/c8bm00553b.

PMID:
30019709
22.

Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.

Musunuru K, Sheikh F, Gupta RM, Houser SR, Maher KO, Milan DJ, Terzic A, Wu JC; American Heart Association Council on Functional Genomics and Translational Biology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular and Stroke Nursing.

Circ Genom Precis Med. 2018 Jan;11(1):e000043. doi: 10.1161/HCG.0000000000000043. Epub 2018 Jan 12. Review.

23.

Fetoscopic Therapy for Severe Pulmonary Hypoplasia in Congenital Diaphragmatic Hernia: A First in Prenatal Regenerative Medicine at Mayo Clinic.

Ruano R, Klinkner DB, Balakrishnan K, Novoa Y Novoa VA, Davies N, Potter DD, Carey WA, Colby CE, Kolbe AB, Arendt KW, Segura L, Sviggum HP, Lemens MA, Famuyide A, Terzic A.

Mayo Clin Proc. 2018 Jun;93(6):693-700. doi: 10.1016/j.mayocp.2018.02.026.

PMID:
29803315
24.

Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions.

Bartunek J, Terzic A, Behfar A, Wijns W.

Circ Res. 2018 May 11;122(10):1344-1346. doi: 10.1161/CIRCRESAHA.118.312753. Review. No abstract available.

25.

Reply to the Letter to the Editor: Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study.

Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ.

Clin Orthop Relat Res. 2018 May;476(5):1129-1130. doi: 10.1007/s11999.0000000000000284. No abstract available.

26.

Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study.

Houdek MT, Wyles CC, Collins MS, Howe BM, Terzic A, Behfar A, Sierra RJ.

Clin Orthop Relat Res. 2018 Feb;476(2):388-397. doi: 10.1007/s11999.0000000000000033.

27.

First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery.

Sherman W, Bartunek J, Dolatabadi D, Sanz-Ruiz R, Beleslin B, Wojakowski W, Heyndrickx G, Kimpalou JZ, Waldman SA, Laarman GJ, Seron A, Behfar A, Latere JP, Terzic A, Wijns W; CHART Program.

JACC Cardiovasc Interv. 2018 Feb 26;11(4):412-414. doi: 10.1016/j.jcin.2017.10.036. No abstract available.

28.

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS Writing Group.

Circ Res. 2018 Jan 19;122(2):199-201. doi: 10.1161/CIRCRESAHA.117.312099. No abstract available.

PMID:
29348246
29.

Process Improvement for Maximized Therapeutic Innovation Outcome.

Waldman SA, Terzic A.

Clin Pharmacol Ther. 2018 Jan;103(1):8-12. doi: 10.1002/cpt.929.

30.

Insulin-like peptide 3 expressed in the silkworm possesses intrinsic disulfide bonds and full biological activity.

Miyazaki T, Ishizaki M, Dohra H, Park S, Terzic A, Kato T, Kohsaka T, Park EY.

Sci Rep. 2017 Dec 11;7(1):17339. doi: 10.1038/s41598-017-17707-1.

31.

Posology for Regenerative Therapy.

Terzic A, Behfar A.

Circ Res. 2017 Nov 10;121(11):1213-1215. doi: 10.1161/CIRCRESAHA.117.312074. No abstract available.

32.

Conventional and unconventional secretory proteins expressed with silkworm bombyxin signal peptide display functional fidelity.

Park S, Arrell DK, Reyes S, Park EY, Terzic A.

Sci Rep. 2017 Nov 3;7(1):14499. doi: 10.1038/s41598-017-14833-8.

33.

Regenerative Musculoskeletal Care: Ensuring Practice Implementation.

Saris DBF, de Windt TS, Vonk LA, Krych AJ, Terzic A.

Clin Pharmacol Ther. 2018 Jan;103(1):50-53. doi: 10.1002/cpt.883. Epub 2017 Oct 16. No abstract available.

PMID:
29034457
34.

Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics.

Waldman SA, Terzic A.

Clin Pharmacol Ther. 2017 Sep;102(3):373-377. doi: 10.1002/cpt.763.

35.

Affairs of the Heart: Innovation in Cardiovascular Research and Development.

Honig P, Terzic A.

Clin Pharmacol Ther. 2017 Aug;102(2):162-168. doi: 10.1002/cpt.737.

PMID:
28718903
36.

Global position paper on cardiovascular regenerative medicine.

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group; Authors/Task Force Members. Chairpersons; Basic Research Subcommittee; Translational Research Subcommittee; Challenges of Cardiovascular Regenerative Medicine Subcommittee; Tissue Engineering Subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee; Clinical Trials Subcommittee; Regulatory and funding strategies subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee.

Eur Heart J. 2017 Sep 1;38(33):2532-2546. doi: 10.1093/eurheartj/ehx248. No abstract available. Erratum in: Eur Heart J. 2018 May 14;39(19):1723.

37.

Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.

Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, Terzic A, Gersh BJ, Povsic TJ, Henry TD, Alexandre B, Homsy C, Edwards C, Seron A, Wijns W, Cotter G; CHART Investigators.

Eur J Heart Fail. 2017 Nov;19(11):1520-1529. doi: 10.1002/ejhf.898. Epub 2017 May 31.

38.

Store-operated Ca2+ entry supports contractile function in hearts of hibernators.

Nakipova OV, Averin AS, Evdokimovskii EV, Pimenov OY, Kosarski L, Ignat'ev D, Anufriev A, Kokoz YM, Reyes S, Terzic A, Alekseev AE.

PLoS One. 2017 May 22;12(5):e0177469. doi: 10.1371/journal.pone.0177469. eCollection 2017.

39.

Functionalized Carbon Nanotube and Graphene Oxide Embedded Electrically Conductive Hydrogel Synergistically Stimulates Nerve Cell Differentiation.

Liu X, Miller AL 2nd, Park S, Waletzki BE, Zhou Z, Terzic A, Lu L.

ACS Appl Mater Interfaces. 2017 May 3;9(17):14677-14690. doi: 10.1021/acsami.7b02072. Epub 2017 Apr 20.

PMID:
28406608
40.

Make regeneration great again; stronger together.

Behfar A, Terzic A.

Eur Heart J. 2017 Apr 14;38(15):1094-1095. doi: 10.1093/eurheartj/ehx151. No abstract available.

PMID:
30052838
41.

Sport and scholastic factors in relation to smoking and smoking initiation in older adolescents: a prospective cohort study in Bosnia and Herzegovina.

Sekulic D, Sisic N, Terzic A, Jasarevic I, Ostojic L, Pojskic H, Zenic N.

BMJ Open. 2017 Mar 22;7(3):e014066. doi: 10.1136/bmjopen-2016-014066.

42.

Clinical Pharmacology & Therapeutics: Past, Present, and Future.

Waldman SA, Terzic A.

Clin Pharmacol Ther. 2017 Mar;101(3):300-303. doi: 10.1002/cpt.592.

43.

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.

Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guédès A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W; CHART Program.

Eur Heart J. 2017 Mar 1;38(9):648-660. doi: 10.1093/eurheartj/ehw543.

44.

Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.

Waldman SA, Terzic A.

Clin Pharmacol Ther. 2017 Jan;101(1):8-12. doi: 10.1002/cpt.551. Epub 2016 Nov 21.

45.

CardioPulse: Regenerative medicine in the practice of cardiology.

Terzic A, Behfar A.

Eur Heart J. 2016 Apr 7;37(14):1089-90. No abstract available.

PMID:
27512734
46.

Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability.

Perales-Clemente E, Cook AN, Evans JM, Roellinger S, Secreto F, Emmanuele V, Oglesbee D, Mootha VK, Hirano M, Schon EA, Terzic A, Nelson TJ.

EMBO J. 2016 Sep 15;35(18):1979-90. doi: 10.15252/embj.201694892. Epub 2016 Jul 19.

47.

Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs.

Kang E, Wang X, Tippner-Hedges R, Ma H, Folmes CD, Gutierrez NM, Lee Y, Van Dyken C, Ahmed R, Li Y, Koski A, Hayama T, Luo S, Harding CO, Amato P, Jensen J, Battaglia D, Lee D, Wu D, Terzic A, Wolf DP, Huang T, Mitalipov S.

Cell Stem Cell. 2016 May 5;18(5):625-36. doi: 10.1016/j.stem.2016.02.005. Epub 2016 Apr 14.

48.

Is Prevention of Glaucoma Possible in Bosnia and Herzegovina?

Terzic S, Jusufovic V, Vodencarevic AN, Asceric M, Pilavdzic A, Halilbasic M, Terzic A.

Med Arch. 2016 Apr;70(2):140-1. doi: 10.5455/medarh.2016.70.140-141. Epub 2016 Apr 1.

49.

Collagen and Fractionated Platelet-Rich Plasma Scaffold for Dermal Regeneration.

Houdek MT, Wyles CC, Stalboerger PG, Terzic A, Behfar A, Moran SL.

Plast Reconstr Surg. 2016 May;137(5):1498-506. doi: 10.1097/PRS.0000000000002094.

PMID:
27119924
50.

Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.

Wyles SP, Hrstka SC, Reyes S, Terzic A, Olson TM, Nelson TJ.

Clin Transl Sci. 2016 Jun;9(3):158-67. doi: 10.1111/cts.12393. Epub 2016 Apr 22.

Supplemental Content

Loading ...
Support Center